A Multicenter Registry to Evaluate the Long-term Safety and Tolerability of Maintenance Treatment With Iron Sucrose (Venofer) in Pediatric Patients Ages ≥ 2 to ≤ 17 Years With Chronic Kidney Disease
Phase of Trial: Phase IV
Latest Information Update: 17 May 2017
At a glance
- Drugs Iron sucrose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions
- Sponsors Luitpold Pharmaceuticals
- 25 Jan 2016 Planned End Date changed from 1 Dec 2016 to 1 Jan 2018 as reported by ClinicalTrials.gov record.
- 25 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 23 Jul 2015 New trial record